BlackRock Inc. - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 31 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$169,000
+59.4%
83,714
+12.6%
0.00%
Q1 2022$106,000
-7.0%
74,357
+6.5%
0.00%
Q4 2021$114,000
-46.2%
69,825
+5.2%
0.00%
Q3 2021$212,000
-90.6%
66,352
-85.4%
0.00%
Q2 2021$2,246,000
-28.0%
454,743
+20.3%
0.00%
Q1 2021$3,119,000
+4231.9%
378,036
+874.2%
0.00%
Q4 2020$72,000
+118.2%
38,804
+0.7%
0.00%
Q3 2020$33,000
-13.2%
38,549
+0.0%
0.00%
Q2 2020$38,000
-2.6%
38,546
-0.8%
0.00%
Q1 2020$39,00038,8560.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 181,169$259,0000.01%
CarsonAllaria Wealth Management, Ltd. 2,350$3,0000.00%
Engineers Gate Manager LP 15,428$22,0000.00%
Virtu Financial LLC 13,555$19,0000.00%
OSAIC HOLDINGS, INC. 1,602$3,0000.00%
FMR LLC 14$00.00%
US BANCORP \DE\ 2,000$3,0000.00%
WELLS FARGO & COMPANY/MN 1,682$2,0000.00%
NORTHERN TRUST CORP 42,000$60,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders